USE OF PIPERAZINE COMPOUND IN COMBINATION WITH RADIOTHERAPY FOR TREATMENT OF TUMOR

Title:

USE OF PIPERAZINE COMPOUND IN COMBINATION WITH RADIOTHERAPY FOR TREATMENT OF TUMOR

Document Type and Number:

WIPO Patent Application WO/2024/032409

Kind Code:

A1

Abstract:

The present application relates to the use of a piperazine compound in combination with radiotherapy for the treatment of a tumor.

More Like This:

WO/2017/158570	METHOD OF TREATING TRIPLE NEGATIVE BREAST CANCER
JPH05247055	STAUROSPORINE DERIVATIVE AND ANTIULCER EFFECT ENHANCER CONTAINING THE SAME DERIVATIVE
JP4045469	Glycosides of novel serine derivatives

Inventors:

ZHU YUQIN (CN)
WEI YONGGANG (CN)
CHU HONGZHU (CN)
YE FEI (CN)
SU GUIZHUAN (CN)
SUN YI (CN)

Application Number:

PCT/CN2023/110230

Publication Date:

February 15, 2024

Filing Date:

July 31, 2023

Export Citation:

Click for automatic bibliography generation Help

Assignee:

CHENGDU BAIYU PHARMACEUTICAL CO LTD (CN)

International Classes:

A61P35/00; A61K31/4985; C07D471/04

Domestic Patent References:

WO2022242750A1

2022-11-24

Foreign References:

CN112424188A	2021-02-26
CN112812113A	2021-05-18
CN113906031A	2022-01-07
US20110230472A1	2011-09-22

Attorney, Agent or Firm:

BEIJING SANYOU INTELLECTUAL PROPERTY AGENCY LTD. (CN)

Download PDF:

View/Download PDF PDF Help

Previous Patent: HINGE OF FLEXIBLE SCREEN MOBILE TERMINAL

Next Patent: COMPOSITION OF PIPERAZINE COMPOUND AND PD-1 INHIBITOR OR PD-L1 INHIBITOR AND USE THEREOF IN TREATING...